![SARS‐CoV‐2 Omicron variant: A next phase of the COVID‐19 pandemic and a call to arms for system sciences and precision medicine - Mostafavi - 2022 - MedComm - Wiley Online Library SARS‐CoV‐2 Omicron variant: A next phase of the COVID‐19 pandemic and a call to arms for system sciences and precision medicine - Mostafavi - 2022 - MedComm - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0ee3c50f-cd88-4f3d-93f5-925d3a481998/mco2119-gra-0001-m.jpg?trick=1686271309216)
SARS‐CoV‐2 Omicron variant: A next phase of the COVID‐19 pandemic and a call to arms for system sciences and precision medicine - Mostafavi - 2022 - MedComm - Wiley Online Library
![JCM | Free Full-Text | The Bivalent COVID-19 Booster Immunization after Three Doses of Inactivated Vaccine Augments the Neutralizing Antibody Response against Circulating Omicron Sublineages JCM | Free Full-Text | The Bivalent COVID-19 Booster Immunization after Three Doses of Inactivated Vaccine Augments the Neutralizing Antibody Response against Circulating Omicron Sublineages](https://pub.mdpi-res.com/jcm/jcm-12-00146/article_deploy/html/images/jcm-12-00146-g001-550.jpg?1672217312)
JCM | Free Full-Text | The Bivalent COVID-19 Booster Immunization after Three Doses of Inactivated Vaccine Augments the Neutralizing Antibody Response against Circulating Omicron Sublineages
![Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The](https://www.thelancet.com/cms/attachment/8e33f9d1-8d6e-4d59-93c0-3a3d193f7cd0/gr2_lrg.jpg)
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The
![Omicron felled me, but like the unheard tree in the forest I couldn't prove it | Brigid Delaney | The Guardian Omicron felled me, but like the unheard tree in the forest I couldn't prove it | Brigid Delaney | The Guardian](https://i.guim.co.uk/img/media/7ac64bd25949ea823dc0a7e596d0202e15324283/0_574_4768_2860/master/4768.jpg?width=1200&height=1200&quality=85&auto=format&fit=crop&s=c2ac7c407e2747d15ebcf5bdc21fca94)
Omicron felled me, but like the unheard tree in the forest I couldn't prove it | Brigid Delaney | The Guardian
![SCD Children With Omicron Infection at Risk of Severe Symptoms | Over 80% of SCD Children With COVID-19 Variant Admitted to ICU | Sickle Cell Anemia News SCD Children With Omicron Infection at Risk of Severe Symptoms | Over 80% of SCD Children With COVID-19 Variant Admitted to ICU | Sickle Cell Anemia News](https://sicklecellanemianews.com/wp-content/uploads/2022/01/Cells.png)
SCD Children With Omicron Infection at Risk of Severe Symptoms | Over 80% of SCD Children With COVID-19 Variant Admitted to ICU | Sickle Cell Anemia News
![Omicron Variant in Karnataka: Three weeks since first infection, no Omicron cluster in Karnataka | Bengaluru News - Times of India Omicron Variant in Karnataka: Three weeks since first infection, no Omicron cluster in Karnataka | Bengaluru News - Times of India](https://static.toiimg.com/thumb/msid-88316533,width-1280,resizemode-4/88316533.jpg)
Omicron Variant in Karnataka: Three weeks since first infection, no Omicron cluster in Karnataka | Bengaluru News - Times of India
![Frontiers | Symptom diaries as a digital tool to detect SARS-CoV-2 infections and differentiate between prevalent variants Frontiers | Symptom diaries as a digital tool to detect SARS-CoV-2 infections and differentiate between prevalent variants](https://www.frontiersin.org/files/Articles/1030939/fpubh-10-1030939-HTML/image_m/fpubh-10-1030939-g001.jpg)
Frontiers | Symptom diaries as a digital tool to detect SARS-CoV-2 infections and differentiate between prevalent variants
![Safety and immunogenicity following a homologous booster dose of CoronaVac in children and adolescents | Nature Communications Safety and immunogenicity following a homologous booster dose of CoronaVac in children and adolescents | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-34280-y/MediaObjects/41467_2022_34280_Fig1_HTML.png)